Harmony Biosciences Holdings Inc (HRMY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2017 | 12-2006 | 12-2005 | |
| Sales | 159,742 | 5,995 | 0 | 0 | 0 |
| Cost of Goods | 27,738 | 1,577 | N/A | N/A | N/A |
| Gross Profit | 132,004 | 4,418 | N/A | N/A | N/A |
| Operating Expenses | 115,756 | 150,899 | 0 | 0 | 0 |
| Operating Income | 16,986 | -145,904 | N/A | N/A | N/A |
| Interest Expense | 28,220 | 6,073 | 0 | 0 | 0 |
| Other Income | -25,710 | 0 | 0 | 0 | 0 |
| Pre-tax Income | -36,944 | -151,977 | 0 | 0 | 0 |
| Net Income Continuous | -36,944 | -151,977 | N/A | N/A | N/A |
| Net Income | $-36,944 | $-151,977 | $N/A | $N/A | $N/A |
| EPS Basic Total Ops | -2.48 | -24.07 | N/A | N/A | N/A |
| EPS Basic Continuous Ops | -1.43 | -19.54 | N/A | N/A | N/A |
| EPS Diluted Total Ops | -2.48 | -24.07 | N/A | N/A | N/A |
| EPS Diluted Continuous Ops | -1.43 | -19.54 | N/A | N/A | N/A |
| EPS Diluted Before Non-Recurring Items | 0.21 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $29,635 | $-142,102 | $N/A | $N/A | $N/A |